The WHO is looking to patent pools to prevent blocking IP and give earlier access to generics manufacturers as part of a plan to improve healthcare in developing countries.
China needs a better return on its fast-rising investments in R&D and higher education if it is to become an “innovation-oriented” economy by 2020, OECD.
The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.